title: Re: current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).
authors.forename: David P
authors.initials: DP
authors.lastname: Wood
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage*; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011159:Population Surveillance / Q000379:methods*; D018570:Risk Assessment / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D001500:BCG Vaccine